Erratum: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma (Oncotarget (2016) 7 (7816–7828) Doi:10.18632/oncotarget.6868)

Ke Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, Monika Deshpande, Brooks Puchner, Fabiana Kashiwabuchi, Syed Junaid Hassan, Laura Asnaghi, James T. Handa, Shannath L Merbs, Charles G. Eberhart, Gregg L. Semenza, Silvia Montaner, Akrit Sodhi

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has been corrected: In Figure 1, panel D, two of the HIF-1 alpha images were mislabeled. Specifically, the HIF-1 alpha image of OCM1 cells exposed to 1% oxygen was labeled as “DFO” and the HIF-1 alpha image of OCM1 cells exposed to DFO was labeled as “1% oxygen.” The corrected Figure 1 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original languageEnglish (US)
Pages (from-to)519-520
Number of pages2
JournalOncotarget
Volume12
Issue number5
DOIs
StatePublished - Mar 2 2021

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Erratum: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma (Oncotarget (2016) 7 (7816–7828) Doi:10.18632/oncotarget.6868)'. Together they form a unique fingerprint.

Cite this